drugset / Trial / NCT00561951
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of fesoterodine in comparison to placebo for overactive bladder.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | Oral |
| Subject | Fesoterodine | Other / unclassified | 8 mg | Oral |